23andMe Faces Bankruptcy Amid Privacy Concerns and Leadership Changes
The genetic testing giant's financial troubles raise questions about the security and future of millions of users' DNA data.
Overview
- 23andMe, once a leader in direct-to-consumer genetic testing, is nearing bankruptcy due to financial struggles and a massive data breach.
- The company's stock value has plummeted by over 97% since its peak following its public listing in 2021.
- A data breach in 2023 compromised the genetic data of nearly 7 million users, leading to a $30 million class action lawsuit settlement.
- Anne Wojcicki, CEO and co-founder, plans to take the company private, rejecting third-party takeover proposals to maintain data privacy commitments.
- Despite privacy assurances, there is growing consumer concern about the potential sale or transfer of genetic data if the company is sold or restructured.